GEODE CAPITAL MANAGEMENT, LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,567,131
-27.7%
2,071,353
+13.3%
0.00%0.0%
Q2 2023$9,084,081
+5.1%
1,827,782
+4.5%
0.00%0.0%
Q1 2023$8,641,270
+80411.2%
1,749,244
+2.5%
0.00%
-50.0%
Q4 2022$10,733
-99.9%
1,706,460
+4.8%
0.00%
-33.3%
Q3 2022$17,589,000
+5.1%
1,628,667
+10.9%
0.00%
+50.0%
Q2 2022$16,742,000
+45.7%
1,468,606
+16.4%
0.00%
+100.0%
Q1 2022$11,489,000
-44.2%
1,261,251
-8.5%
0.00%
-50.0%
Q4 2021$20,573,000
-36.5%
1,378,903
+9.4%
0.00%
-50.0%
Q3 2021$32,383,000
+1.1%
1,260,053
+2.6%
0.00%0.0%
Q2 2021$32,028,000
-15.4%
1,228,081
+14.5%
0.00%
-33.3%
Q1 2021$37,870,000
+51.7%
1,072,831
+8.5%
0.01%
+50.0%
Q4 2020$24,959,000
-29.7%
988,906
+5.0%
0.00%
-42.9%
Q3 2020$35,520,000
-8.4%
941,926
+4.0%
0.01%
-12.5%
Q2 2020$38,798,000
+171.5%
906,077
+23.2%
0.01%
+100.0%
Q1 2020$14,292,000
-59.5%
735,237
-45.9%
0.00%0.0%
Q4 2019$35,282,000
+98.2%
1,358,108
+107.9%
0.00%0.0%
Q3 2019$17,802,000
+60.3%
653,185
+58.0%
0.00%
+33.3%
Q2 2019$11,102,000
+23.5%
413,514
+33.0%
0.00%
+50.0%
Q1 2019$8,987,000
-47.7%
310,889
-51.3%
0.00%
-33.3%
Q4 2018$17,184,000638,1360.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$45,386,0009.32%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$472,400,0005.23%
Wildcat Capital Management, LLC 1,515,524$38,252,0004.81%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 900,143$22,720,0003.28%
Coastal Bridge Advisors, LLC 385,824$9,738,0001.93%
Casdin Capital, LLC 945,000$23,852,0000.71%
DSAM Partners (London) Ltd 208,798$5,270,0000.62%
BAINCO INTERNATIONAL INVESTORS 152,839$3,858,0000.44%
Pier Capital, LLC 152,071$3,838,0000.41%
Woodline Partners LP 567,539$14,325,0000.38%
View complete list of ALLOGENE THERAPEUTICS INC shareholders